Pietro Bertino

1.0k total citations
25 papers, 779 citations indexed

About

Pietro Bertino is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Pietro Bertino has authored 25 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Pietro Bertino's work include Occupational and environmental lung diseases (13 papers), Immunotherapy and Immune Responses (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Pietro Bertino is often cited by papers focused on Occupational and environmental lung diseases (13 papers), Immunotherapy and Immune Responses (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Pietro Bertino collaborates with scholars based in United States, Italy and Germany. Pietro Bertino's co-authors include Michele Carbone, Giovanni Gaudino, Harvey I. Pass, Haining Yang, Sandro Jube, Zeyana Rivera, Luciano Mutti, Camillo Porta, Guido Franzoso and Marco E. Bianchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Pietro Bertino

25 papers receiving 766 citations

Peers

Pietro Bertino

PRM

IMMUN

ONCOL

BIOTE

Sandro Jube United States

Monica Cipollini Italy

Rupak Pathak United States

T R Quinlan United States

Kunihiro Akimaru Japan

Rhonda J. Staversky United States

Marianne Kjalke Denmark

J.F. Lechner United States

Dikaia Xenaki Australia

Liangping Su China

Sandro Jube United States

Pietro Bertino

439 ×1.0

PRM

255 ×1.3

226 ×2.0

IMMUN

123 ×1.1

ONCOL

78 ×0.9

BIOTE

Citations per year, relative to Pietro Bertino Pietro Bertino (= 1×) peers Sandro Jube

Countries citing papers authored by Pietro Bertino

Since Specialization

Citations

This map shows the geographic impact of Pietro Bertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Bertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Bertino more than expected).

Fields of papers citing papers by Pietro Bertino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Bertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Bertino. The network helps show where Pietro Bertino may publish in the future.

Co-authorship network of co-authors of Pietro Bertino

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Bertino. A scholar is included among the top collaborators of Pietro Bertino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Bertino. Pietro Bertino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cerbone, Luigi, Sara Delfanti, Marinella Bertolotti, et al.. (2023). Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens. Thoracic Cancer. 14(5). 524–527. 4 indexed citations

Cerbone, Luigi, et al.. (2023). Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. Cancers. 15(24). 5716–5716. 1 indexed citations

Hoffmann, Peter R., FuKun W. Hoffmann, Thomas A. Premeaux, et al.. (2019). Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in Oncology. 9. 720–720. 8 indexed citations

Bertino, Pietro, Thomas A. Premeaux, Tsuyoshi Fujita, et al.. (2019). Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion. OncoImmunology. 8(8). 1601482–1601482. 21 indexed citations

Khadka, Vedbar S., Youping Deng, Pietro Bertino, et al.. (2018). Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis. Oncotarget. 9(17). 13407–13422. 29 indexed citations

Rose, Aaron H., et al.. (2017). Calpain‐2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Medicine. 7(1). 175–183. 8 indexed citations

Rose, Aaron H., et al.. (2015). Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. Inflammatory Bowel Diseases. 21(9). 2005–2015. 15 indexed citations

Hoffmann, Peter R., Maddalena Panigada, Elisa Soprana, et al.. (2015). Preclinical development of HIvax: Human survivin highly immunogenic vaccines. Human Vaccines & Immunotherapeutics. 11(7). 1585–1595. 12 indexed citations

Rose, Aaron H., FuKun W. Hoffmann, Johann Urschitz, et al.. (2015). Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses. Human Vaccines & Immunotherapeutics. 11(9). 2305–2311. 3 indexed citations

10.

Rose, Aaron H., Pietro Bertino, FuKun W. Hoffmann, et al.. (2014). Increasing Dietary Selenium Elevates Reducing Capacity and ERK Activation Associated with Accelerated Progression of Select Mesothelioma Tumors. American Journal Of Pathology. 184(4). 1041–1049. 13 indexed citations

11.

Bertino, Pietro, Johann Urschitz, FuKun W. Hoffmann, et al.. (2014). Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8+ T cell responses. Vaccine. 32(15). 1670–1677. 7 indexed citations

12.

Bertino, Pietro, Maddalena Panigada, Elisa Soprana, et al.. (2013). Fowlpox‐based survivin vaccination for malignant mesothelioma therapy. International Journal of Cancer. 133(3). 612–623. 16 indexed citations

13.

Nasu, Masanori, Michele Carbone, Giovanni Gaudino, et al.. (2011). Ranpirnase Interferes with NF- B Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth. Genes & Cancer. 2(5). 576–584. 24 indexed citations

14.

Carbone, Michele, Y. Izzettin Bariş, Pietro Bertino, et al.. (2011). Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences. 108(33). 13618–13623. 160 indexed citations

15.

Aceto, Nicola, Pietro Bertino, Dario Barbone, et al.. (2009). Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma. European Respiratory Journal. 34(6). 1399–1407. 22 indexed citations

16.

Bertino, Pietro, Michele Carbone, & Harvey I. Pass. (2008). Chemotherapy of malignant pleural mesothelioma. Expert Opinion on Pharmacotherapy. 10(1). 99–107. 10 indexed citations

17.

Rivera, Zeyana, Oriana Strianese, Pietro Bertino, et al.. (2008). The relationship between simian virus 40 and mesothelioma. Current Opinion in Pulmonary Medicine. 14(4). 316–321. 21 indexed citations

18.

Catassi, Alessia, Laura Paleari, Denis Servent, et al.. (2008). Targeting α7-nicotinic receptor for the treatment of pleural mesothelioma. European Journal of Cancer. 44(15). 2296–2311. 23 indexed citations

19.

Bertino, Pietro, Anna Maria Marconi, Dario Barbone, et al.. (2007). Erionite and asbestos differently cause transformation of human mesothelial cells. International Journal of Cancer. 121(1). 12–20. 37 indexed citations

20.

Bertino, Pietro, Camillo Porta, Dario Barbone, et al.. (2007). Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed. Thorax. 62(8). 690–695. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact